Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniele Masarone

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Kardiologia Polska|February 23, 2022
Last before-death alert remote monitoring transmission in patients with heart failure with reduced ejection fractionDaniele Masarone
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 29, 2020
Repeated infusion of levosimendan in outpatients with advanced heart failure: to cure sometimes, to relieve often, and to comfort alwaysDaniele Masarone, Giuseppe Pacileo
Kardiologia Polska|May 20, 2024
The public health burden of cardiomyopathies: A call for actionDaniele Masarone, Luigi Falco
Kardiologia Polska|January 8, 2024
Restrictive cardiomyopathies: The need for better characterization of a deadly diseaseDaniele Masarone, Luigi Falco
Expert Review of Medical Devices|May 20, 2023
HOPE for a better selection of patients for cardiac contractility modulationDaniele Masarone, Ishu Rao, Giuseppe Pacileo
Heart (British Cardiac Society)|November 9, 2016
Mitochondrial disease and the heartGiuseppe Limongelli, Daniele Masarone, Giuseppe Pacileo
Heart Failure Reviews|November 4, 2021
Use of disease-modifying drugs in diabetic patients with heart failure with reduced ejection fractionDaniele Masarone, Roberta Pacileo, Giuseppe Pacileo
World Journal of Cardiology|March 31, 2025
Shedding light on the effects of sodium-glucose cotransporter 2 inhibitors in the early stages of heart failureLuigi Falco, Emilio Di Lorenzo, Daniele Masarone
Reviews in Cardiovascular Medicine|March 1, 2022
Advanced heart failure: state of the art and future directionsDaniele Masarone, Michelle Kittleson, Andrea Petraio, et al.
Journal of Cardiovascular Development and Disease|September 26, 2021
The Use of β-Blockers in Heart Failure with Reduced Ejection FractionDaniele Masarone, Maria Luigia Martucci, Vittoria Errigo, et al.
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Kardiologia Polska|February 23, 2022
Last before-death alert remote monitoring transmission in patients with heart failure with reduced ejection fractionDaniele Masarone
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 29, 2020
Repeated infusion of levosimendan in outpatients with advanced heart failure: to cure sometimes, to relieve often, and to comfort alwaysDaniele Masarone, Giuseppe Pacileo
Kardiologia Polska|May 20, 2024
The public health burden of cardiomyopathies: A call for actionDaniele Masarone, Luigi Falco
Kardiologia Polska|January 8, 2024
Restrictive cardiomyopathies: The need for better characterization of a deadly diseaseDaniele Masarone, Luigi Falco
Expert Review of Medical Devices|May 20, 2023
HOPE for a better selection of patients for cardiac contractility modulationDaniele Masarone, Ishu Rao, Giuseppe Pacileo
Heart (British Cardiac Society)|November 9, 2016
Mitochondrial disease and the heartGiuseppe Limongelli, Daniele Masarone, Giuseppe Pacileo
Heart Failure Reviews|November 4, 2021
Use of disease-modifying drugs in diabetic patients with heart failure with reduced ejection fractionDaniele Masarone, Roberta Pacileo, Giuseppe Pacileo
World Journal of Cardiology|March 31, 2025
Shedding light on the effects of sodium-glucose cotransporter 2 inhibitors in the early stages of heart failureLuigi Falco, Emilio Di Lorenzo, Daniele Masarone
Reviews in Cardiovascular Medicine|March 1, 2022
Advanced heart failure: state of the art and future directionsDaniele Masarone, Michelle Kittleson, Andrea Petraio, et al.
Journal of Cardiovascular Development and Disease|September 26, 2021
The Use of β-Blockers in Heart Failure with Reduced Ejection FractionDaniele Masarone, Maria Luigia Martucci, Vittoria Errigo, et al.
Pageof 12